Role of marginal vitamin C deficiency in atherogenesis: In vivo models and clinical studies

Basic and Clinical Pharmacology and Toxicology

Volumn 104, Issue 6, 2009, Pages 419-433

  Frikke Schmidt, Henriette ^a   Lykkesfeldt, Jens ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE; PHOSPHOLIPID; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANTIOXIDANT ACTIVITY; AORTA ATHEROSCLEROSIS; ASCORBIC ACID DEFICIENCY; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; DRUG MEGADOSE; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; EXPERIMENTAL MODEL; GUINEA PIG; HUMAN; HYPERCHOLESTEROLEMIA; KIDNEY ARTERY STENOSIS; LIPID METABOLISM; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; RENOVASCULAR DISEASE; RENOVASCULAR HYPERTENSION; RISK ASSESSMENT; SCURVY; SHORT SURVEY; VASODILATATION; VITAMIN BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; ASCORBIC ACID DEFICIENCY; ATHEROSCLEROSIS; COENZYMES; DISEASE MODELS, ANIMAL; DYSLIPIDEMIAS; ENDOTHELIUM, VASCULAR; HUMANS; LIPID METABOLISM; LIPIDS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SCURVY; VASODILATION;

EID: 65549098273     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2009.00420.x     Document Type: Short Survey

References (189)

1. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol 2004 15 : 1983 92. (Pubitemid 39031337)
2. Schulz E, Anter E, Keaney JF, Jr. Oxidative stress, antioxidants, and endothelial function. Curr Med Chem 2004 11 : 1093 104. (Pubitemid 38585055)
3. Wrieden WL, Hannah MK, Bolton-Smith C, Tavendale R, Morrison C, Tunstall-Pedoe H. Plasma vitamin C and food choice in the third Glasgow MONICA population survey. J Epidemiol Community Health 2000 54 : 355 60. (Pubitemid 30204270)
4. Hampl JS, Taylor CA, Johnston CS. Vitamin C deficiency and depletion in the United States: the Third National Health and Nutrition Examination Survey, 1988 to 1994. Am J Public Health 2004 94 : 870 5. (Pubitemid 38560397)
5. Lykkesfeldt J. Smoking depletes Vitamin C: should smokers be recommended to take supplements. In : Halliwell BB, Poulsen HE, (eds). Cigarette Smoke and Oxidative Stress, Berlin Heidelberg: Springer Verlag, 2006 : 237 60.
6. Jacob RA. Assessment of human vitamin C status. J Nutr 1990 120 (Suppl11) : 1480 5.
7. Lykkesfeldt J, Christen S, Wallock LM, Chang HH, Jacob RA, Ames BN. Ascorbate is depleted by smoking and repleted by moderate supplementation: a study in male smokers and nonsmokers with matched dietary antioxidant intakes. Am J Clin Nutr 2000 71 : 530 6. (Pubitemid 30061233)
8. Siomek A, Gackowski D, Rozalski R, Dziaman T, Szpila A, Guz J et al. Higher leukocyte 8-oxo-7,8-dihydro-2′-deoxyguanosine and lower plasma ascorbate in aging humans? Antioxid Redox Signal 2007 9 : 143 50.
9. Cunningham JJ, Ellis SL, McVeigh KL, Levine RE, Calles-Escandon J. Reduced mononuclear leukocyte ascorbic acid content in adults with insulin-dependent diabetes mellitus consuming adequate dietary vitamin C. Metabolism 1991 40 : 146 9.
10. Johnston CS, Beezhold BL, Mostow B, Swan PD. Plasma vitamin C is inversely related to body mass index and waist circumference but not to plasma adiponectin in nonsmoking adults. J Nutr 2007 137 : 1757 62. (Pubitemid 47037703)
11. Gintr E. Chronic vitamin C deficiency increases the risk of cardiovascular diseases. Bratisl Lek Listy 2007 108 : 417 21.
12. Gey KF, Stahelin HB, Eichholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel Prospective Study. Clin Investig 1993 71 : 3 6. (Pubitemid 23041967)
13. Nyyssonen K, Parviainen MT, Salonen R, Tuomilehto J, Salonen JT. Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland. BMJ 1997 314 : 634 8. (Pubitemid 27099877)
14. Langlois M, Duprez D, Delanghe J, De BM, Clement DL. Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation 2001 103 : 1863 8. (Pubitemid 32328399)
15. Fidlar E, Sheppard M, McHenry EW. The physiological properties of ascorbic acid: the increase in metabolism of guinea-pigs on a diet deficient in ascorbic acid. Biochem J 1939 33 : 344 6.
16. Fox FW, Levy LF. Experiments confirming the antiscorbutic activity of dehydroascorbic acid and a study of its storage and that of ascorbic acid by the guinea-pig at different levels of intake. Biochem J 1936 30 : 211 7.
17. Willis GC. An experimental study of intimal ground substance in atherosclerosis. Can Med Assoc J 1953 69 : 17 22.
18. Willis GC. The reversibility of atherosclerosis. Can Med Assoc J 1957 77 : 106 8.
19. Ginter E, Bobek P, Gerbelova M. The effect of acute deficiency and of prolonged low intake of vitamin C on the spectrum of serum lipoproteins in guinea pigs. Bratisl Lek Listy 1965 45 : 11 6.
20. Ginter E, Bilisics L, Cerven J. Cholesterol metabolism under conditions of acute and chronic vitamin C deficiency in guinea-pigs. Physiol Bohemoslov 1965 14 : 466 71.
21. Ginter E. [Effect of vitamin C on the metabolism of cholesterol and atherogenesis]. Cesk Fysiol 1968 17 : 423 36.
22. Ginter E, Bobek P, Vargova D. Tissue levels and optimum dosage of vitamin C in guinea pigs. Nutr Metab 1979 23 : 217 26. (Pubitemid 9126871)
23. Jenkins SA. Vitamin C status, serum cholesterol levels and bile composition in the pregnant guinea-pig. Br J Nutr 1980 43 : 95 100. (Pubitemid 10053536)
24. Ginter E, Ondreicka R, Bobek P, Simko V. The influence of chronic vitamin C deficiency on fatty acid composition of blood serum, liver triglycerides and cholesterol esters in guinea pigs. J Nutr 1969 99 : 261 6.
25. Bjorkhem I, Kallner A. Hepatic 7α-hydroxylation of cholesterol in ascorbate-deficient and ascorbate-supplemented guinea pigs. J Lipid Res 1976 17 : 360 5.
26. Ginter E, Bobek P, Babala J, Barbierikova E. The effect of ascorbic acid on the lipid metabolism of guinea-pigs fed an atherogenic diet. Cor Vasa 1969 11 : 65 73.
27. Ginter E, Babala J, Cerven J. The effect of chronic hypovitaminosis C on the metabolism of cholesterol and atherogenisis in guinea pigs. J Atheroscler Res 1969 10 : 341 52.
28. Sulkin NM, Sulkin DF. Tissue changes induced by marginal vitamin C deficiency. Ann N Y Acad Sci 1975 258 : 317 28.
29. Nambisan B, Kurup PA. Ascorbic acid and glycosaminoglycan and lipid metabolism in guinea pigs fed normal and atherogenic diets. Atherosclerosis 1975 22 : 447 61.
30. Zloch Z. Changes in the cholesterol content of high-density plasma lipoproteins in guinea pigs in the presence of a raised exogenous cholesterol intake and different degrees of vitamin C saturation. Physiol Bohemoslov 1982 31 : 557 62. (Pubitemid 13158942)
31. Satinder, Sarkar AK, Majumdar S, Chakravarti RN. Effect of ascorbic acid deficiency on the development of experimental atherosclerosis. Indian J Med Res 1987 86 : 351 60.
32. Ginter E, Jurcovicova M. Chronic vitamin C deficiency lowers fractional catabolic rate of low-density lipoproteins in guinea pigs. Ann N Y Acad Sci 1987 498 : 473 5.
33. Kothari LK, Sharma P. Aggravation of cholesterol induced hyperlipidemia by chronic vitamin C deficiency: experimental study in guinea pigs. Acta Biol Hung 1988 39 : 49 57.
34. Sharma P, Pramod J, Sharma PK, Chaturvedi SK, Kothari LK. Effect of vitamin C administration on serum & aortic lipid profile of guineapigs. Indian J Med Res 1988 87 : 283 9. (Pubitemid 18140674)
35. Rath M, Pauling L. Immunological evidence for the accumulation of lipoprotein(a) in the atherosclerotic lesion of the hypoascorbemic guinea pig. Proc Natl Acad Sci USA 1990 87 : 9388 90. (Pubitemid 120030631)
36. Sen S, Mukherjee S. Interrelationship of dietary lipids and ascorbic acid with hepatic enzymes of cholesterol metabolic pathway. Indian J Exp Biol 1997 35 : 42 5. (Pubitemid 127492189)
37. Roomi MW. Association between hyperlipidemia and hepatic cytochrome P-450 in guinea pigs. Res Commun Mol Pathol Pharmacol 1997 97 : 139 50. (Pubitemid 27430542)
38. Fernandez ML, Vega S, Ayala MT, Shen H, Conde K, Vergara-Jimenez M et al. Vitamin C level and dietary fat saturation alter hepatic cholesterol homeostasis and plasma LDL metabolism in guinea pigs. J Nutr Biochem 1997 8 : 414 24. (Pubitemid 27344882)
39. Montano CE, Fernandez ML, McNamara DJ. Regulation of apolipoprotein B-containing lipoproteins by vitamin C level and dietary fat saturation in guinea pigs. Metabolism 1998 47 : 883 91. (Pubitemid 2831320)
40. Weinstein M, Babyn P, Zlotkin S. An orange a day keeps the doctor away: scurvy in the year 2000. Pediatrics 2001 108 : E55.
41. Hirschmann JV, Raugi GJ. Adult scurvy. J Am Acad Dermatol 1999 41 : 895 906.
42. Ginter E. Marginal vitamin C deficiency, lipid metabolism, and atherogenesis. Adv Lipid Res 1978 16 : 167 220.
43. Fernandez ML, Volek JS. Guinea pigs: A suitable animal model to study lipoprotein metabolism, atherosclerosis and inflammation. Nutr Metab (Lond) 2006 3 : 17.
44. West KL, Fernandez ML. Guinea pigs as models to study the hypocholesterolemic effects of drugs. Cardiovasc Drug Rev 2004 22 : 55 70. (Pubitemid 38379634)
45. Fernandez ML. Guinea pigs as models for cholesterol and lipoprotein metabolism. J Nutr 2001 131 : 10 20. (Pubitemid 32060616)
46. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996 3 : 213 9. (Pubitemid 26266496)
47. Shen BW, Scanu AM, Kezdy FJ. Structure of human serum lipoproteins inferred from compositional analysis. Proc Natl Acad Sci USA 1977 74 : 837 41. (Pubitemid 8068697)
48. Ooi TC, Ooi DS. The atherogenic significance of an elevated plasma triglyceride level. Crit Rev Clin Lab Sci 1998 35 : 489 516. (Pubitemid 29034228)
49. Chapman MJ, Mills GL. Characterization of the serum lipoproteins and their apoproteins in hypercholesterolaemic guinea pigs. Biochem J 1977 167 : 9 21. (Pubitemid 8216981)
50. Shaih M, Wootton R, Nordestgaard BG, Baskerville P, Lumley JS, La Ville AE et al. Quantitative studies of transfer in vivo of low density, Sf 12-60, and Sf 60-400 lipoproteins between plasma and arterial intima in humans. Arterioscler Thromb 1991 11 : 569 77.
51. Rapp JH, Lespine A, Hamilton RL, Colyvas N, Chaumeton AH, Tweedie-Hardman J et al. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler Thromb 1994 14 : 1767 74. (Pubitemid 2164784)
52. Dunn WA, Rettura G, Seifter E, Englard S. Carnitine biosynthesis from gamma-butyrobetaine and from exogenous protein-bound 6-N-trimethyl-L-lysine by the perfused guinea pig liver. Effect of ascorbate deficiency on the in situ activity of gamma-butyrobetaine hydroxylase. J Biol Chem 1984 259 : 10764 70. (Pubitemid 14031200)
53. Nelson PJ, Pruitt RE, Henderson LL, Jenness R, Henderson LM. Effect of ascorbic acid deficiency on the in vivo synthesis of carnitine. Biochim Biophys Acta 1981 672 : 123 7. (Pubitemid 11175945)
54. Ha TY, Otsuka M, Arakawa N. The effect of graded doses of ascorbic acid on the tissue carnitine and plasma lipid concentrations. J Nutr Sci Vitaminol (Tokyo) 1990 36 : 227 34. (Pubitemid 20324774)
55. Camps L, Reina M, Llobera M, gtsson-Olivecrona G, Olivecrona T, Vilaro S. Lipoprotein lipase in lungs, spleen, and liver: synthesis and distribution. J Lipid Res 1991 32 : 1877 88.
56. Vilaro S, Llobera M, gtsson-Olivecrona G, Olivecrona T. Lipoprotein lipase uptake by the liver: localization, turnover, and metabolic role. Am J Physiol 1988 254 : G711 G722. (Pubitemid 18137203)
57. Hasham SN, Pillarisetti S. Vascular lipases, inflammation and atherosclerosis. Clin Chim Acta 2006 372 : 179 83. (Pubitemid 44286780)
58. Frick M, Weidinger F. Endothelial function: a surrogate endpoint in cardiovascular studies? Curr Pharm Des 2007 13 : 1741 50. (Pubitemid 46979712)
59. Jablonski KL, Seals DR, Eskurza I, Monahan KD, Donato AJ. High-dose ascorbic acid infusion abolishes chronic vasoconstriction and restores resting leg blood flow in healthy older men. J Appl Physiol 2007 103 : 1715 21. (Pubitemid 350033857)
60. Holowatz LA, Thompson CS, Kenney WL. Acute ascorbate supplementation alone or combined with arginase inhibition augments reflex cutaneous vasodilation in aged human skin. Am J Physiol Heart Circ Physiol 2006 291 : H2965 H2970.
61. Singh N, Graves J, Taylor PD, MacAllister RJ, Singer DR. Effects of a 'healthy' diet and of acute and long-term vitamin C on vascular function in healthy older subjects. Cardiovasc Res 2002 56 : 118 25. (Pubitemid 35247808)
62. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996 97 : 22 8. (Pubitemid 26021690)
63. Timimi FK, Ting HH, Haley EA, Roddy MA, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 1998 31 : 552 7. (Pubitemid 28144120)
64. Hirai N, Kawano H, Hirashima O, Motoyama T, Moriyama Y, Sakamoto T et al. Insulin resistance and endothelial dysfunction in smokers: effects of vitamin C. Am J Physiol Heart Circ Physiol 2000 279 : H1172 H1178.
65. Beckman JA, Goldfine AB, Gordon MB, Creager MA. Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans. Circulation 2001 103 : 1618 23. (Pubitemid 32246607)
66. Heitzer T, Finckh B, Albers S, Krohn K, Kohlschutter A, Meinertz T. Beneficial effects of α-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress. Free Radic Biol Med 2001 31 : 53 61. (Pubitemid 32568424)
67. Mullan BA, Ennis CN, Fee HJ, Young IS, McCance DR. Pretreatment with intravenous ascorbic acid preserves endothelial function during acute hyperglycaemia (R1). Clin Exp Pharmacol Physiol 2005 32 : 340 5. (Pubitemid 40780256)
68. Arcaro G, Cretti A, Balzano S, Lechi A, Muggeo M, Bonora E et al. Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 2002 105 : 576 82. (Pubitemid 34123431)
69. Evans M, Anderson RA, Smith JC, Khan N, Graham JM, Thomas AW et al. Effects of insulin lispro and chronic vitamin C therapy on postprandial lipaemia, oxidative stress and endothelial function in patients with type 2 diabetes mellitus. Eur J Clin Invest 2003 33 : 231 8. (Pubitemid 36411541)
70. Darko D, Dornhorst A, Kelly FJ, Ritter JM, Chowienczyk PJ. Lack of effect of oral vitamin C on blood pressure, oxidative stress and endothelial function in Type II diabetes. Clin Sci (Lond) 2002 103 : 339 44. (Pubitemid 35193236)
71. Antoniades C, Tousoulis D, Tountas C, Tentolouris C, Toutouza M, Vasiliadou C et al. Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: the effects of vitamin C. Diabet Med 2004 21 : 552 8. (Pubitemid 38746273)
72. Chen H, Karne RJ, Hall G, Campia U, Panza JA, Cannon RO, III et al. High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance. Am J Physiol Heart Circ Physiol 2006 290 : H137 H145.
73. Tousoulis D, Antoniades C, Vasiliadou C, Kourtellaris P, Koniari K, Marinou K et al. Effects of atorvastatin and vitamin C on forearm hyperaemic blood flow, asymmentrical dimethylarginine levels and the inflammatory process in patients with type 2 diabetes mellitus. Heart 2007 93 : 244 6. (Pubitemid 46180305)
74. Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF, Jr., Vita JA. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996 93 : 1107 13. (Pubitemid 26087013)
75. Ito K, Akita H, Kanazawa K, Yamada S, Terashima M, Matsuda Y et al. Comparison of effects of ascorbic acid on endothelium-dependent vasodilation in patients with chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy versus patients with effort angina pectoris secondary to coronary artery disease. Am J Cardiol 1998 82 : 762 7. (Pubitemid 28439637)
76. Gokce N, Keaney JF, Jr, Frei B, Holbrook M, Olesiak M, Zachariah BJ et al. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1999 99 : 3234 40. (Pubitemid 29293432)
77. Hamabe A, Takase B, Uehata A, Kurita A, Ohsuzu F, Tamai S. Impaired endothelium-dependent vasodilation in the brachial artery in variant angina pectoris and the effect of intravenous administration of vitamin C. Am J Cardiol 2001 87 : 1154 9. (Pubitemid 32453234)
78. Tousoulis D, Xenakis C, Tentolouris C, Davies G, Antoniades C, Crake T et al. Effects of vitamin C on intracoronary l-arginine dependent coronary vasodilatation in patients with stable angina. Heart 2005 91 : 1319 23. (Pubitemid 41360952)
79. Erbs S, Gielen S, Linke A, Mobius-Winkler S, Adams V, Baither Y et al. Improvement of peripheral endothelial dysfunction by acute vitamin C application: different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy. Am Heart J 2003 146 : 280 5. (Pubitemid 36951772)
80. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001 104 : 2673 8. (Pubitemid 33108132)
81. Hornig B, Landmesser U, Kohler C, Ahlersmann D, Spiekermann S, Christoph A et al. Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase. Circulation 2001 103 : 799 805. (Pubitemid 32163876)
82. Landmesser U, Merten R, Spiekermann S, Buttner K, Drexler H, Hornig B. Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 2000 101 : 2264 70. (Pubitemid 30317128)
83. Drossos GE, Toumpoulis IK, Katritsis DG, Ioannidis JP, Kontogiorgi P, Svarna E et al. Is vitamin C superior to diltiazem for radial artery vasodilation in patients awaiting coronary artery bypass grafting? J Thorac Cardiovasc Surg 2003 125 : 330 5. (Pubitemid 36228310)
84. Ting HH, Timimi FK, Haley EA, Roddy MA, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation 1997 95 : 2617 22. (Pubitemid 27255489)
85. Perticone F, Ceravolo R, Maio R, Cloro C, Candigliota M, Scozzafava A et al. Effects of atorvastatin and vitamin C on endothelial function of hypercholesterolemic patients. Atherosclerosis 2000 152 : 511 8.
86. John S, Schneider MP, Delles C, Jacobi J, Schmieder RE. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients. Am Heart J 2005 149 : 473. (Pubitemid 40585410)
87. Virdis A, Pinto S, Versari D, Salvetti G, Bernini G, Fruzzetti F et al. Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women. J Hypertens 2003 21 : 2275 80. (Pubitemid 38293566)
88. Schindler TH, Nitzsche EU, Munzel T, Olschewski M, Brink I, Jeserich M et al. Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: contrasting myocardial blood flow responses to short- and long-term vitamin C administration. J Am Coll Cardiol 2003 42 : 814 22. (Pubitemid 37059738)
89. Pullin CH, Bonham JR, McDowell IF, Lee PJ, Powers HJ, Wilson JF et al. Vitamin C therapy ameliorates vascular endothelial dysfunction in treated patients with homocystinuria. J Inherit Metab Dis 2002 25 : 107 18. (Pubitemid 34700299)
90. Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR, Haynes WG. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation 1999 100 : 1161 8. (Pubitemid 29426590)
91. Virdis A, Ghiadoni L, Cardinal H, Favilla S, Duranti P, Birindelli R et al. Mechanims responsible for endothelial dysfunction induced by fasting hyperhomocystinemia in normotensive subjects and patients with essential hypertension. J Am Coll Cardiol 2001 38 : 1106 15. (Pubitemid 32912719)
92. Chambers JC, McGregor A, Jean-Marie J, Obeid OA, Kooner JS. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy. Circulation 1999 99 : 1156 60. (Pubitemid 29120086)
93. Hanratty CG, McGrath LT, McAuley DF, Young IS, Johnston DG. The effect on endothelial function of vitamin C during methionine induced hyperhomocysteinaemia. BMC Cardiovasc Disord 2001 1 : 1. (Pubitemid 38824789)
94. Labinjoh C, Newby DE, Wilkinson IB, Megson IL, MacCallum H, Melville V et al. Effects of acute methionine loading and vitamin C on endogenous fibrinolysis, endothelium-dependent vasomotion and platelet aggregation. Clin Sci (Lond) 2001 100 : 127 35. (Pubitemid 32165356)
95. Pleiner J, Schaller G, Mittermayer F, Bayerle-Eder M, Roden M, Wolzt M. FFA-induced endothelial dysfunction can be corrected by vitamin C. J Clin Endocrinol Metab 2002 87 : 2913 7. (Pubitemid 34655363)
96. Steer P, Millgard J, Basu S, Lithell H, Vessby B, Berne C et al. Vitamin C, diclophenac, and l-arginine protect endothelium-dependent vasodilation against elevated circulating fatty acid levels in humans. Atherosclerosis 2003 168 : 65 72. (Pubitemid 36555812)
97. Bayerle-Eder M, Pleiner J, Mittermayer F, Schaller G, Roden M, Waldhausl W et al. Effect of systemic vitamin C on free fatty acid-induced lipid peroxidation. Diabetes Metab 2004 30 : 433 9. (Pubitemid 39648011)
98. Watanabe S, Tagawa T, Yamakawa K, Shimabukuro M, Ueda S. Inhibition of the renin-angiotensin system prevents free fatty acid-inuced acute endothelial dysfunction in humans. Arterioscler Thromb Vasc Biol 2005 25 : 2376 80. (Pubitemid 41552657)
99. Ling L, Zhao SP, Gao M, Zhou QC, Li YL, Xia B. Vitamin C preserves endothelial function in patients with coronary heart disease after a high-fat meal. Clin Cardiol 2002 25 : 219 24. (Pubitemid 34457364)
100. Solzbach U, Hornig B, Jeserich M, Just H. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation 1997 96 : 1513 9. (Pubitemid 27375345)
101. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 1998 97 : 2222 9. (Pubitemid 28265383)
102. Natali A, Sironi AM, Toschi E, Camastra S, Sanna G, Perissinotto A et al. Effect of vitamin C on forearm blood flow and glucose metabolism in essential hypertension. Arterioscler Thromb Vasc Biol 2000 20 : 2401 6.
103. Sherman DL, Keaney JF, Jr., Biegelsen ES, Duffy SJ, Coffman JD, Vita JA. Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. Hypertension 2000 35 : 936 41. (Pubitemid 30303954)
104. On YK, Kim CH, Sohn DW, Oh BH, Lee MM, Park YB et al. Improvement of endothelial function by amlodipine and vitamin C in essential hypertension. Korean J Intern Med 2002 17 : 131 7.
105. Schneider MP, Delles C, Schmidt BM, Oehmer S, Schwarz TK, Schmieder RE et al. Superoxide scavenging effects of N-acetylcysteine and vitamin C in subjects with essential hypertension. Am J Hypertens 2005 18 : 1111 7. (Pubitemid 41139911)
106. Holowatz LA,tenney WL. Local ascorbate administration augments NO- and non-NO-dependent reflex cutaneous vasodilation in hypertensive humans. Am J Physiol Heart Circ Physiol 2007 293 : H1090 H1096. (Pubitemid 47254209)
107. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A et al. Age-related reduction of NO availability and oxidative stress in humans. Hypertension 2001 38 : 274 9. (Pubitemid 34224757)
108. Taddei S, Virdis A, Ghiadoni L, Magagna A, Favilla S, Pompella A et al. Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension. Hypertension 2001 37 : 943 8. (Pubitemid 32221618)
109. Taddei S, Virdis A, Ghiadoni L, Versari D, Salvetti G, Magagna A et al. Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension. Hypertension 2003 41 : 950 5. (Pubitemid 36418471)
110. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 2002 346 : 1954 62. (Pubitemid 34651355)
111. Duffy SJ, Gokce N, Holbrook M, Hunter LM, Biegelsen ES, Huang A et al. Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension. Am J Physiol Heart Circ Physiol 2001 280 : H528 H534. (Pubitemid 32466892)
112. Ward NC, Hodgson JM, Croft KD, Burke V, Beilin LJ, Puddey IB. The combination of vitamin C and grape-seed polyphenols increases blood pressure: a randomized, double-blind, placebo-controlled trial. J Hypertens 2005 23 : 427 34. (Pubitemid 40279647)
113. Magen E, Viskoper R, Mishal J, Priluk R, Berezovsky A, Laszt A et al. Resistant arterial hypertension and hyperlipidemia: atorvastatin, not vitamin C, for blood pressure control. Isr Med Assoc J 2004 6 : 742 6. (Pubitemid 39646687)
114. Ward NC, Hodgson JM, Croft KD, Clarke MW, Burke V, Beilin LJ et al. Effects of vitamin C and grape-seed polyphenols on blood pressure in treated hypertensive individuals: results of a randomised double blind, placebo-controlled trial. Asia Pac J Clin Nutr 2003 12 (Suppl) : S18.
115. Pleiner J, Mittermayer F, Schaller G, MacAllister RJ, Wolzt M. High doses of vitamin C reverse Escherichia coli endotoxin-induced hyporeactivity to acetylcholine in the human forearm. Circulation 2002 106 : 1460 4.
116. Cangemi R, Angelico F, Loffredo L, Del BM, Pignatelli P, Martini A et al. Oxidative stress-mediated arterial dysfunction in patients with metabolic syndrome: Effect of ascorbic acid. Free Radic Biol Med 2007 43 : 853 9.
117. Tesauro M, Schinzari F, Rovella V, Melina D, Mores N, Barini A et al. Tumor necrosis factor-α antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome. Diabetes Care 2008 31 : 1439 41.
118. Higashi Y, Sasaki S, Nakagawa K, Kimura M, Noma K, Sasaki S et al. Low body mass index is a risk factor for impaired endothelium-dependent vasodilation in humans: role of nitric oxide and oxidative stress. J Am Coll Cardiol 2003 42 : 256 63. (Pubitemid 36851415)
119. Perticone F, Ceravolo R, Candigliota M, Ventura G, Iacopino S, Sinopoli F et al. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C. Diabetes 2001 50 : 159 65. (Pubitemid 32047995)
120. Hornig B, Arakawa N, Kohler C, Drexler H. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 1998 97 : 363 8. (Pubitemid 28074337)
121. Hirashima O, Kawano, Motoyama T, Hirai N, Ohgushi M, Kugiyama K et al. Improvement of endothelial function and insulin sensitivity with vitamin C in patients with coronary spastic angina: possible role of reactive oxygen species. J Am Coll Cardiol 2000 35 : 1860 6.
122. Ellis GR, Anderson RA, Chirkov YY, Morris-Thurgood J, Jackson SK, Lewis MJ et al. Acute effects of vitamin C on platelet responsiveness to nitric oxide donors and endothelial function in patients with chronic heart failure. J Cardiovasc Pharmacol 2001 37 : 564 70. (Pubitemid 32377912)
123. Richartz BM, Werner GS, Ferrari M, Figulla HR. Reversibility of coronary endothelial vasomotor dysfunction in idiopathic dilated cardiomyopathy: acute effects of vitamin C. Am J Cardiol 2001 88 : 1001 5. (Pubitemid 33042611)
124. Pleiner J, Schaller G, Mittermayer F, Marsik C, MacAllister RJ, Kapiotis S et al. Intra-arterial vitamin C prevents endothelial dysfunction caused by ischemia-reperfusion. Atherosclerosis 2008 197 : 383 91.
125. Heitzer T, Baldus S, von KY, Rudolph V, Meinertz T. Systemic endothelial dysfunction as an early predictor of adverse outcome in heart failure. Arterioscler Thromb Vasc Biol 2005 25 : 1174 9. (Pubitemid 40776605)
126. Ellis GR, Anderson RA, Lang D, Blackman DJ, Morris RH, Morris-Thurgood J et al. Neutrophil superoxide anion-generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short- and long-term vitamin C therapy. J Am Coll Cardiol 2000 36 : 1474 82.
127. Murchie KJ, Jennings GL, Kingwell BA. Supplemental oxygen does not modulate responses to acetylcholine or ascorbic acid in the forearm of patients with congestive heart failure. Clin Sci (Lond) 2000 99 : 57 63. (Pubitemid 30479393)
128. Widlasky ME, Biegelsen ES, Hamburg NM, Duffy SJ, Keaney JF, Jr., Vita JA. Coronary endothelial dysfunction is not rapidly reversible with ascorbic acid. Free Radic Biol Med 2004 36 : 123 30. (Pubitemid 38068297)
129. Cross JM, Donald AE, Nuttall SL, Deanfield JE, Woolfson RG, MacAllister RJ. Vitamin C improves resistance but not conduit artery endothelial function in patients with chronic renal failure. Kidney Int 2003 63 : 1433 42. (Pubitemid 36350008)
130. Ghiadoni L, Cupisti A, Huang Y, Mattei P, Cardinal H, Favilla S et al. Endothelial dysfunction and oxidative stress in chronic renal failure. J Nephrol 2004 17 : 512 9. (Pubitemid 39302878)
131. Williams MJ, Sutherland WH, McCormick MP, de Jong SA, McDonald JR, Walker RJ. Vitamin C improves endothelial dysfunction in renal allograft recipients. Nephrol Dial Transplant 2001 16 : 1251 5. (Pubitemid 32547383)
132. Eskurza I, Monahan KD, Robinson JA, Seals DR. Effect of acute and chronic ascorbic acid on flow-mediated dilatation with sedentary and physically active human ageing. J Physiol 2004 556 : 315 24. (Pubitemid 38519054)
133. Galetta F, Franzoni F, Virdis A, Ghiadoni L, Taddei S, Salvetti A et al. Endothelium-dependent vasodilation and carotid artery wall remodeling in athletes and sedentary subjects. Atherosclerosis 2006 186 : 184 92.
134. Taddei S, Galetta F, Virdis A, Ghiadoni L, Salvetti G, Franzoni F et al. Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes. Circulation 2000 101 : 2896 901. (Pubitemid 30415878)
135. Heitzer T, Just H, Munzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 1996 94 : 6 9. (Pubitemid 126426392)
136. Motoyama T, Kawao H, Kugiyama K, Hirashima O, Ohgushi M, Yoshimura M et al. Endothelium-dependent vasodilation in the brachial artery is impaired in smokers: effect of vitamin C. Am J Physiol 1997 273 : H1644 50. (Pubitemid 27479260)
137. Zhang J, Ying X, Lu Q, Kallner A, Xiu RJ, Henriksson P et al. A single high dose of vitamin C counteracts the acute negative effect on microcirculation induced by smoking a cigarette. Microvasc Res 1999 58 : 305 11. (Pubitemid 29531877)
138. Kaufmann PA, Gnecchi-Ruscone T, di TM, Schafers KP, Luscher TF, Camici PG. Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation 2000 102 : 1233 8.
139. Raitakari OT, Adams MR, McCredie RJ, Griffiths KA, Stocker R, Celermajer DS. Oral vitamin C and endothelial function in smokers: short-term improvement, but no sustained beneficial effect. J Am Coll Cardiol 2000 35 : 1616 21. (Pubitemid 30307508)
140. Stamatelopoulos KS, Lekakis JP, Papamichael CM, Papaioannou TG, Cimboneriou A, Stamatelopoulos SF. Oral administration of ascorbic acid attenuates endothelial dysfunction after short-term cigarette smoking. Int J Vitam Nutr Res 2003 73 : 417 22. (Pubitemid 38009808)
141. Teramoto K, Daimon M, Hasegawa R, Toyoda T, Sekine T, Kawata T et al. Acute effect of oral vitamin C on coronary circulation in young healthy smokers. Am Heart 2004 148 : 300 5. (Pubitemid 39092796)
142. de Sousa MG, Yugar-Toledo JC, Rubira M, Ferreira-Melo SE, Plentz R, Barbieri D et al. Ascorbic acid improves impaired venous and arterial endothelium-dependent dilation in smokers. Acta Pharmacol Sin 2005 26 : 447 52. (Pubitemid 40477993)
143. Kaehler J, Koeke K, Karstens M, Schneppenheim R, Meinertz T, Heitzer T. Impaired capacity for acute endogenous fibrinoysis in smokers is restored by ascorbic acid. Free Radic Biol Med 2008 44 : 315 21.
144. Young JM, Shand BI, McGregor PM, Scott RS, Frampton CM. Comparative effects of enzogenol and vitamin C supplementation versus vitamin C alone on endothelial function and biochemical markers of oxidative stress and inflammation in chronic smokers. Free Radic Res 2006 40 : 85 94. (Pubitemid 43023789)
145. Fennessy FM, Moneley DS, Wang JH, Kelly CJ, Bouchier-Hayes DJ. Taurine and vitamin C modify monocyte and endothelial dysfunction in young smokers. Circulation 2003 107 : 410 5. (Pubitemid 36158042)
146. Pellegrini MP, Newby DE, Johnston NR, Maxwell S, Webb DJ. Vitamin C has no effect on endothelium-dependent vasomotion and acute endogenous fibrinolysis in healthy smokers. J Cardiovasc Pharmacol 2004 44 : 117 24. (Pubitemid 38857137)
147. Hirooka Y, Eshima K, Setoguchi S, Kishi T, Egashira K, Takeshita A. Vitamin C improves attenuated angiotensin II-induced endothelium-dependent vasodilation in human forearm vessels. Hypertens Res 2003 26 : 953 9. (Pubitemid 38128767)
148. Bohm F, Settergren M, Pernow J. Vitamin C blocks vascular dysfunction and release of interleukin-6 induced by endothelin-1 in humans in vivo. Atherosclerosis 2007 190 : 408 15. (Pubitemid 46074032)
149. Protogerou AD, Lekakis JP, Kontoyanni DD, Stamatelopoulos KS, Tsotsoros ND, Papaioannou TG et al. Effect of ascorbic acid on forearm reactive hyperaemia in patients with hypercholesterolaemia. Eur J Cardiovasc Prev Rehabil 2004 11 : 149 54. (Pubitemid 38591086)
150. Van Guilder GP, Hoetzer GL, Greiner JJ, Stauffer BL, DeSouza CA. Acute and chronic effects of vitamin C on endothlial fibrinolytic function in overweight and obese adult humans. J Physiol 2008 586 : 3525 35.
151. Landmesser U, Spiekermann S, Dikalov S, Tatge H, Wilke R, Kohler C et al. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 2002 106 : 3073 8. (Pubitemid 35440291)
152. Versari D, Daghini E, Rodriguez-Porcel M, Sattler K, Galili O, Pilarczyk K et al. Chronic antioxidant supplementation impairs coronary endothelial function and myocardial perfusion in normal pigs. Hypertension 2006 47 : 475 81. (Pubitemid 43740293)
153. Aikawa K, Saitoh S, Muto M, Osugi T, Matsumoto K, Onogi F et al. Effects of antioxidants on coronary microvascular spasm induced by epicardial coronary artery endothelial injury in pigs. Coron Artery Dis 2004 15 : 21 30. (Pubitemid 39117996)
154. Chade AR, Rodriguez-Porcel M, Herrmann J, Zhu X, Grande JP, Napoli C et al. Antioxidant intervention blunts renal injury in experimental renovascular disease. J Am Soc Nephrol 2004 15 : 958 66. (Pubitemid 38375315)
155. Chade AR, Krier JD, Rodriguez-Porcel M, Breen JF, McKusick MA, Lerman A et al. Comparison of acute and chronic antioxidant interventions in experimental renovascular disease. Am J Physiol Renal Physiol 2004 286 : F1079 F1086. (Pubitemid 38656363)
156. Rodriguez-Porcel M, Herrman J, Chade AR, Krier JD, Breen JF, Lerman A et al. Long-term antioxidant intervention improves myocardial microvascular function in experimental hypertension. Hypertension 2004 43 : 493 8. (Pubitemid 38174160)
157. De NF, Demontis MP, Rodriguez-Porcel M, Anania V, Lerman LO, Napoli C. Renal blood flow in hypercholesterolemic pigs is increased by chronic antioxidant treatment. J Vet Pharmacol Ther 2003 26 : 113 6. (Pubitemid 36461254)
158. Rodriguez JA, Grau A, Eguinoa E, Nespereira B, Pérez-Ilzarbe M, Arias R et al. Dietary supplementation with vitamins C and E prevents downregulation of endothelial NOS expression in hypercholesterolemia in vivo and in vitro. Atherosclerosis 2002 165 : 33 40. (Pubitemid 35223165)
159. Rodriguez-Porcel M, Lerman A, Best PJ, Krier JD, Napoli C, Lerman LO. Hypercholesterolemia impairs myocardial perfusion and permeability: role of oxidative stress and endogenous scavenging activity. J Am Coll Cardiol 2001 37 : 608 15. (Pubitemid 32147278)
160. Stulak JM, Lerman A, Porcel MR, Caccitolo JA, Romero JC, Scaff HV et al. Renal vascular function in hypercholesterolemia is preserved by chronic antioxidant supplementation. J Am Soc Nephrol 2001 12 : 1882 91. (Pubitemid 32801363)
161. Simova II, Denchev SV, Dimitrov SI, Ivanova R. Endothelial function in patients with and without diabetes mellitus with different degrees of coronary artery stenosis. J Clin Ultrasound 2009 37 : 35 9.
162. Benjamin EJ, Larson MG, Keyes MJ, Mitchell GF, Vasan RS, Keaney JF, Jr. et al. Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation 2004 109 : 613 9. (Pubitemid 38198868)
163. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993 88 : 2149 55. (Pubitemid 23326094)
164. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007 87 : 315 424. (Pubitemid 46217686)
165. Buettner GR. The pecking order of free radicals and antioxidants: lipid peroxidation, α-tocopherol, and ascorbate. Arch Biochem Biophys 1993 300 : 535 43. (Pubitemid 23232908)
166. May JM, Qu ZC. Ascorbic acid efflux and re-uptake in endothelial cells: maintenance of intracellular ascorbate. Mol Cell Biochem 2009 325 : 79 88.
167. Jackson TS, Xu A, Vita JA, Keaney JF, Jr. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 1998 83 : 916 22. (Pubitemid 28503080)
168. Smith AR, Visioli F, Hagen TM. Vitamin C matters: increased oxidative stress in cultured human aortic endothelial cells without supplemental ascorbic acid. FASEB J 2002 16 : 1102 4.
169. Visioli F, Smith A, Zhang W, Keaney JF, Jr., Hagen T, Frei B. Lipoic acid and vitamin C potentiate nitric oxide synthesis in human aortic endothelial cells independently of cellular glutathione status. Redox Rep 2002 7 : 223 7.
170. Huang A, Vita JA, Venema RC, Keaney JF, Jr. Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem 2000 275 : 17399 406. (Pubitemid 30430776)
171. 2+/ calmodulin-independent diaphorase and reductase activities. Biochemistry 1992 31 : 3243 9.
172. Andrew PJ, Mayer B. Enzymatic function of nitric oxide synthases. Cardiovasc Res 1999 43 : 521 31. (Pubitemid 29369251)
173. Baek KJ, Thiel BA, Lucas S, Stuehr DJ. Macrophage nitric oxide synthase subunits. Purification, characterization, and role of prosthetic groups and substrate in regulating their association into a dimeric enzyme. J Biol Chem 1993 268 : 21120 9. (Pubitemid 23292298)
174. Cai S, Khoo J, Mussa S, Alp NJ, Channon KM. Endothelial nitric oxide synthase dysfunction in diabetic mice: importance of tetrahydrobiopterin in eNOS dimerisation. Diabetologia 2005 48 : 1933 40. (Pubitemid 41317851)
175. Schmidt PP, Lange R, Gorren AC, Werner ER, Mayer B, Andersson KK. Formation of a protonated trihydrobiopterin radical cation in the first reaction cycle of neuronal and endothelial nitric oxide synthase detected by electron paramagnetic resonance spectroscopy. J Biol Inorg Chem 2001 6 : 151 8. (Pubitemid 32822144)
176. Kwon NS, Nathan CF, Stuehr DJ. Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages. J Biol Chem 1989 264 : 20496 501. (Pubitemid 20009238)
177. Fukuda Y, Teragawa H, Matsuda K, Yamagata T, Matsuura H, Chayama K. Tetrahydrobiopterin improves coronary endothelial function, but does not prevent coronary spasm in patients with vasospastic angina. Circ J 2002 66 : 58 62. (Pubitemid 34462432)
178. Fukuda Y, Teragawa H, Matsuda K, Yamagata T, Matsuura H, Chayama K. Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia. Heart 2002 87 : 264 9. (Pubitemid 34177685)
179. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA et al. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 2001 103 : 1282 8. (Pubitemid 32221353)
180. Pannirselvam M, Simon V, Verma S, Anderson T, Triggle CR. Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice. Br J Pharmacol 2003 140 : 701 6. (Pubitemid 37386434)
181. Tiefenbacher CP, Bleeke T, Vahl C, Amann K, Vogt A, Kubler W. Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis. Circulation 2000 102 : 2172 9.
182. Ueda S, Matsuoka H, Miyazaki H, Usui M, Okuda S, Imaizumi T. Tetrahydrobiopterin restores endothelial function in long-term smokers. J Am Coll Cardiol 2000 35 : 71 5. (Pubitemid 30061262)
183. Verma S, Lovren F, Dumont AS, Mather KJ, Maitland A, Kieser TM et al. Tetrahydrobiopterin improves endothelial function in human saphenous veins. J Thorac Cardiovasc Surg 2000 120 : 668 71.
184. Heller R, Unbehaun A, Schellenberg B, Mayer B, Werner-Felmayer G, Werner ER. L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem 2001 276 : 40 7. (Pubitemid 32050286)
185. Bingham S, Luben R, Welch A, Low YL, Khaw KT, Wareham N et al. Associations between dietary methods and biomarkers, and between fruits and vegetables and risk of ischaemic heart disease, in the EPIC Norfolk Cohort Study. Int J Epidemiol 2009 [Epub ahead of Print].
186. Khaw KT, Bingham S, Welch A, Luben R, Wareham N, Oakes S et al. Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. European Prospective Investigation into Cancer and Nutrition. Lancet 2001 357 : 657 63.
187. Schectman G, Byrd JC, Gruchow HW. The influence of smking on vitamin C status in adults. Am J Public Health 1989 79 : 158 62. (Pubitemid 19052359)
188. Blanchard J, Tozer TN, Rowland M. Pharmacokinetic perspectives on megadoses of ascorbic acid. Am J Clin Nutr 1997 66 : 1165 71. (Pubitemid 27473340)
189. Nakata Y, Maeda N. Vulnerable atherosclerotic plaque morphology in apolipoprotein E-deficient mice unable to make ascorbic Acid. Circulation 2002 105 : 1485 90. (Pubitemid 34263282)